Syrris’ Free Flow Chemistry Workshops in High Demand
News Feb 06, 2015
Syrris enjoyed another successful global series of flow chemistry seminars in 2014. These free events, which combine theoretical discussion with hands-on sessions, enabled chemists to develop their understanding of the many and varied benefits of flow chemistry.
Flow chemistry has emerged as an exciting technology for research and development chemists over the last decade, enabling a wide variety of chemical reactions to be quickly and easily performed, as well as allowing integration of synthesis, work-up and analysis in a single workflow.
As a market leader in the sector, Syrris has been offering free flow chemistry seminars for three years, and the 2014 series - which included events in Denmark, Switzerland, USA, UK, Germany, Belgium, France, Mexico, Sweden and Japan - proved more popular than ever.
Delegates from a wide range of backgrounds took advantage of the company’s extensive knowledge and experience to learn how to perform reactions that are not possible using traditional techniques, seeing for themselves how flow chemistry can provide safer, faster and cleaner reactions.
Dr Laure Théveau, a postdoctoral fellow at the KTH Royal Institute of Technology, Sweden, attended the Stockholm workshop and commented: “Flow chemistry is becoming increasingly common in scientific literature, and I was keen to learn more about the technique. Both the theoretical and practical sessions were very complementary, combining clear explanations and an overview of the technique with detailed technical information and advice on troubleshooting. I would certainly recommend the workshops to anyone looking at implementing flow chemistry methods in their laboratory.”
Novel Chemistry Technique Simplifies Late-Stage Modification of Drug CompoundsNews
Chemists at The Scripps Research Institute (TSRI) have invented a technique that overcomes a long-standing problem in organic chemistry and should streamline the process of discovery and development for many new drugs.READ MORE
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE